Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings

December 2013 in “ Journal of Investigative Dermatology Symposium Proceedings ”

David A. Norris

alopecia areata innate immunity acquired immunity NKG2D ligands IL-15 CTLA-4 JAK signaling pathways immune privilege antigen-specific T cells

Studysummary This review discusses recent advances in the understanding of alopecia areata, focusing on immunity and genetics, and presents potential targets for therapy without reporting new clinical results. Our plain-language summary of this paper — not a Tressless recommendation.

The first day of the Alopecia Areata Research Summit in 2013 reviewed advancements in understanding the genetic and immunologic factors of alopecia areata (AA). It was found that both innate and acquired immunity played roles in AA, with genetic studies revealing complex immunologic networks. Key treatment targets identified included NKG2D ligands, IL-15, CTLA-4, and JAK signaling pathways. The modulation of immune privilege was also considered as a potential management strategy. However, the specificity of the immune response in AA, particularly the role of antigen-specific T cells or antibodies, remained unclear. The summit highlighted the need for a strong clinical research platform to test new treatments and further explore these findings.

View this study on jidsponline.org →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research The Genetics of Alopecia Areata: What's New and How Will It Help Our Patients?

43 citations , May 2011 in “Dermatologic therapy”

This study identified at least eight genetic regions associated with alopecia areata, which may lead to the development of new targeted therapies based on these findings.

research Genome-Wide Association Study in Alopecia Areata Implicates Both Innate and Adaptive Immunity

717 citations , June 2010 in “Nature”

This study identified key genetic regions associated with alopecia areata, highlighting both acquired and innate immune involvement, with a novel link to the upregulation of ULBP ligands in autoimmune disease.